-
Mucus plug gene expression could identify new COPD targets
Recent research has identified distinct gene clusters that may underly the clinical heterogeneity of mucus pathology and inform further studies, investigator Ehab Billatos, MD, said.
Recent News
-
Get to know 2026 CHEST President Neil Freedman, MD, FCCP
Hear about what President Neil Freedman, MD, FCCP, would like to accomplish throughout the next 12 months and learn what he needs from you.
-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
-
Data show OSA is an independent, modifiable risk factor for cerebral microbleeds
The first prospective, longitudinal study of OSA and cerebral microbleeds (CMBs) found that moderate to severe OSA more than doubles the risk for microbleeds.
-
Targeting capillary refill time identified as superior resuscitation strategy
Yuri Matusov, MD, said recent findings mark a significant step toward an individualized approach for managing septic shock.
-
Trials suggest RSV vaccine reduces hospitalization for cardiorespiratory conditions in older adults
Data from studies in the United States and Denmark add to the growing evidence that respiratory syncytial virus (RSV) vaccination is effective in older adults.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
